Among these targets, the CERES score of ELN in most CRC cell lines was close to zero, suggesting that ELN might be crucial for CRC, and blocking its function in high PRS group patients could lead to a favorable treatment outcome. This evidence concerns the gene ELN and colorectal carcinoma.